Strand Therapeutics is a clinical stage biotechnology company utilizing synthetic biology to genetically program mRNA to deliver truly revolutionary immunotherapies to patients.
Strand Therapeutics is seeking a highly motivated and innovative Associate Scientist I for Nanoparticle Process Development. The successful candidate will support the production and scale-up of LNPs with nucleic acid payload, contribute to the development of a robust formulation process, and collaborate with internal stakeholders on characterization and tech-transfer efforts.
Strand Therapeutics is a clinical stage biotechnology company utilizing synthetic biology to genetically program mRNA to deliver truly revolutionary immunotherapies to patients.